Publications by authors named "David Tamang"

Claim this Profile
E
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy.
Matthew D Hellmann, Pasi A Jänne, Mateusz Opyrchal, Navid Hafez, Luis E Raez, David Tamang

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.
Brian J North, Ingrid Almeciga-Pinto, David Tamang, Min Yang, Simon S Jones

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.
Dan T Vogl, Noopur Raje, Sundar Jagannath, Paul Richardson, Parameswaran Hari, David Tamang

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.
Andrew J Yee, William I Bensinger, Jeffrey G Supko, Peter M Voorhees, Jesus G Berdeja, David L Tamang

Lancet Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
Jeffrey R Shearstone, Olga Golonzhka, Apurva Chonkar, David Tamang, John H van Duzer

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.
David L Tamang, Waheed Pirzai, Gregory P Priebe, David C Traficante, Gerald B Pier

J Immunol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.
Loredana Santo, Teru Hideshima, Andrew L Kung, Jen-Chieh Tseng, David Tamang

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.
Bryce N Alves, Jeff Leong, David L Tamang, Viki Elliott, Jillian Edelnant

J Leukoc Biol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs).
Bryce N Alves, Kristen Marshall, David L Tamang, Jeffrey Leong, Doug Redelman

Cell Biochem Funct· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrolysis of tumor cell lipids after CTL-mediated death.
Bryce Alves, Jeff Leong, David L Tamang, Viki Elliott, Mark Lowe

Int Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of perforin lysis: implications for protein disulfide isomerase proteins.
David L Tamang, Bryce N Alves, Viki Elliott, Doug Redelman, Renu Wadhwa

Cell Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen.
David L Tamang, Bryce N Alves, Viki Elliott, Stephanie A Fraser, Doug Redelman

Cell Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition.
William H D Hallett, Erik Ames, Milad Motarjemi, Isabel Barao, Anil Shanker, David L Tamang

J Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
David L Tamang, Doug Redelman, Bryce N Alves, Leanne Vollger, Christy Bethley

Cytokine· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis